text:
Landhuis Bloemhof is een landhuis in Curaçao, gelegen aan de Santa Rosaweg in Willemstad. Het is in gebruik als museum annex galerie.

Geschiedenis
Landhuis Bloemhof is gebouwd in de achttiende eeuw. Aanvankelijk heette het Landhuis Nooit gedacht. Het stond op een zogenaamde waterplantage: op het terrein werd water opgeslagen in putten en verkocht voor gebruik op het land en voor de schoonmaak. Daarnaast werd regenwater als drinkwater verkocht. Later werd op de plantage van het landhuis laraha verbouwd, een citrusvrucht die onder andere gebruikt wordt voor het maken van de likeur Blue Curaçao.

Bloemhof is vaak van eigenaar gewisseld. De eerste verkoop vond plaats in 1735, maar sinds 1919 is het landhuis in bezit van dezelfde familie. Beeldhouwer en schrijver May Henriquez (1915-1999), kleindochter van de oorspronkelijke eigenaar, logeerde in de vakanties vaak lange tijd bij haar oma op Bloemhof. Door haar toedoen werd Bloemhof in de jaren vijftig van de twintigste eeuw een ontmoetingsplaats voor schrijvers, dichters, schilders, beeldhouwers en andere kunstenaars. De Curaçaose kunstenaarsstroming de Trappisten hield in 1956 haar tweede grote groepsexpositie hier. Tegenwoordig is Bloemhof een museum annex expositieruimte. De dochters van May Henriquez hebben in 2003 een stichting in het leven geroepen om het culturele aspect te waarborgen. Er zijn doorlopend exposities Caribische kunst, en er worden lezingen, workshops, cursussen en concerten gegeven.

In het landhuis staat veel kunst en antiek uit Curaçao en elders, en onder meer een gedeelte van de kunstverzameling van de familie Henriquez. In het winkeltje zijn boeken over het eiland te koop en kleurrijke souvenirs die gemaakt zijn op het eiland. Het atelier van May Henriquez is gevestigd in een langwerpig gebouw naast het hoofdgebouw. Het is gerestaureerd in dezelfde staat als toen zij er nog werkte. In hetzelfde gebouw is ook een bibliotheek met voornamelijk beeldende-kunstboeken, kunstenaarsarchieven en vele toneelscripts in het Papiaments. In de tuin van het landhuis staat een oud badhuis en een zwembad met waterputten, waterreservoirs en een dam. Ook zijn daar een beeldentuin, het atelier van beeldhouwer Hortence Brouwn en de kathedraal van doornen van Herman van Bergen te vinden.

Architectuur
Landhuis Bloemhof is gebouwd in Mediterrane stijl. Het hoofdgebouw van twee verdiepingen is symmetrisch en heeft een zadeldak met dakkapellen. De open zijgalerijen en zijvleugels hebben schuine daken.

Bouwwerk in Willemstad
Cultuur in Curaçao
Museum in Curaçao

redpajama_set_name: RedPajamaWikipedia


text:
Why health's gender pay gap is a problem for everyone
How governments can fight inequality in the health workforce
How to break the glass walls holding Argentine women back at work
The gender pay gap by country: mapped
The cost of healthcare is crippling the lives of millions of women and girls
Within the health workforce, men occupy around three quarters of senior roles, yet women make up around 70% of the world's workers. And while women in health contribute 5% to the world's gross domestic product — a staggering $3 trillion every year — half of that work goes unrecognised and unpaid.
So found the authors of the WHO's most recent report on gender equality in the global health workforce, which makes for grim reading. Women in global health are subject to persistent gender inequalities within the workforce which impede their career progression, depress global economic output, and hinder progress towards improving global health, the report found.
But what's causing gender inequality in the global health workforce? Why does it matter? And what policies could change it?
Equality's pay offs
Gender biases in societies across the world encourage men and women into different jobs: where men are encouraged into technical, well-paid roles including surgery and management, women are instead led into lower-paid, less secure caregiving roles as community health workers, nurses and midwives.
Those social expectations curtail both men's and women's choices: "Just as a woman might benefit from a leadership role, a man might benefit from a caregiving role," said Dr Geordan Shannon, researcher at the Institute for Global Health, University College London.
Education plays a significant part in that. Girls in low- and middle-income countries often struggle to receive secondary education or reach university, curbing their potential for progression into global health's higher rungs. Those that do reach the formal global health workforce often face a motherhood penalty.
But gender inequality isn't purely driven by social factors: across the world, employment rights, equal pay for equal work and protections against harassment are threadbare or non-existent in many legal systems.
Without effective redress for gender-based violence and harassment, pay equality and collective bargaining enshrined in law, women are necessarily held back.
The impact of these inequalities is far reaching, according to the WHO report, impacting the quality of care provided, and the economic potential of the sector at large.
"Gender equality in the global health workforce is both an intrinsic value in and of itself, and something more instrumental," said Shannon. Helping women to flourish within the workforce is a moral imperative in any fair society, she argued, but it could also improve quality of care and a range of other global development outcomes.
According to the WHO, gender equality in global health would reap a triple dividend.
First, research by the International Monetary Fund, McKinsey and the World Economic Forum in other sectors have found that diversity and gender equality within workforces align with improved productivity and efficiency, which in global health could mean significant progress towards the WHO's goal of universal health coverage by 2030.
Second, improving women's working conditions, pay and quality of life in the world's health systems — which between them employ a significant proportion of the population — could make significant progress towards achieving gender equality in society at large.
Finally, the global health and social sector is projected to create some 40 million new jobs by 2030. Holding back or discriminating against the workers who overwhelmingly fill those roles is also a blow to the world's economic development.
Data and decisions
Investing in proper data gathering is the bedrock for intelligent policy, but many countries, especially in the global south, remain largely in the dark about the impact of gender inequality within their workforces.
The WHO's most recent report relies heavily on studies in the global north, the findings of which are unlikely to apply neatly elsewhere. The solutions too are likely to be different.
That said, lack of data is no excuse to delay policy change, said Geordan Shannon. "We don't need to wait for the full picture of evidence; we have sufficient information on hand to know that gender equality in the global health workforce offers immense rewards."
The aim, she and others argue, is to stop trying to force women to fit the global health system, and start trying to make the system work for women. According to Roopa Dhatt, co-founder of Women in Global Health, "Policies to date have attempted to fix women to fit into inequitable systems; now we need to fix the system and work environment to create decent work for women and close gender gaps in leadership and pay."
One vital area that can be addressed now is parental leave and flexible working policies for all, said Sarah Hawkes, Professor of Global Public Health, UCL and co-founder of Global Health 50/50.
"You need strong parental leave policies. Evidence suggests that it's no good just having the option of paid paternity leave, there's an argument that it should be mandated, because if it's just shared then women take most of it," she said. Simply expanding leave to men is unlikely to dramatically change when social expectations discourage men from becoming primary caregivers to children.
"You also need childcare for people with young children, otherwise women are often the ones forced to fill that role," Kent Buse, Chief of Strategic Policy Directions at UNAIDS added. "And you need flexible working arrangements for everyone in the workforce, whether you're a man or woman, to facilitate caring for children or any other family member, or simply to have more of a work-life balance," he said.
As it stands, research by Global Health 50/50 found that some 200 leading global health organisations differ dramatically in terms of both parental leave and flexible working policies: standardising the most progressive policies would go a significant way in narrowing global health's gender gap.
Ending the men-lead, women-deliver model is a new era in the fight for gender equality in health. Where previous struggles fought simply to put women's health issues on the agenda, researchers now stress the need to understand gender as one of the most significant determinants of health, and to understand what gender justice means when women aren't simply the recipients of care — they're the vast majority of the global health providers.
According to Geordan Shannon, "It's not just a women's issue: it's about what's best for everyone." — Edward Siddons
(Picture credit: Flickr/Ilmicrofono Oggiono)
How sex and gender influence the way we vote
In London's city hall, we've got a new plan to close the gender gap
The Gender Equality Top 100 — Apolitical publishes the inaugural list
Join for free Log In to leave a comment.
Invite a connection
Know smart, curious people working to improve government? Invite them to apply to Apolitical. We prioritise any invitations from existing members.
We've added you to the guest list and we'll be in touch with more information soon.
Can't find what you're looking for here? Our team will answer up to three questions by doing additional research or consulting our network - for free...
Suggest a policy
Have you worked on a policy innovation or successful programme that should be featured here? Tell us about it!
Your idea*

redpajama_set_name: RedPajamaCommonCrawl


Records whether any member of the household accesses the internet from the dwelling. This includes accessing the internet through a desktop/laptop computer, mobile or smart phone, tablet, music or video player, gaming console, smart TV or any other devices . It also includes accessing through any type of connection for example ADSL, fibre, cable, wireless, satellite and mobile broadband (3G/4G).


text:
Home / News / Classic Cars
Replica of long-lost Briggs Cunningham Corvette shows up at Le Mans
Viknesh Vijayenthiran July 6, 2016 Comment Now!
Update: This car is a replica of the Briggs Cunningham #1 1960 Chevrolet Corvette and not the original as stated in an earlier version of the story.
A 1960 Chevrolet Corvette long thought lost to history was finally found in 2012. The car was one of three Corvettes fielded in the 1960 24 Hours of Le Mans by legendary American sportsman Briggs Cunningham.
A superb replica depicting the car in its original state was displayed on the sidelines of the 2016 24 Hours of Le Mans held in June, and thanks to the keen eye at Motor.es we have some photos of it.
The original car was the #1 Corvette that Cunningham actually drove at Le Mans, though it never finished due to a crash. After the race it was converted for drag racing and subsequently ended up in a junk yard. A Florida man bought it in 1972 but not knowing its significance left it to rot in a warehouse.
Briggs Cunningham Chevrolet Corvettes at the 1960 24 Hours of Le Mans
That man's son, Richard Carr, in 2012 learned of its significance after doing a VIN search on the Internet. It was sold that same year to Lance Miller who through his father already owned the #3 Corvette fielded by Cunningham in the 1960 Le Mans race (the #2 Corvette is owned by collector Bruce Meyer).
Miller in 2012 sold the car for $75,000 to Corvette restorer Kevin Mackay, who had been searching for it for decades. Together they planned to present it at the 2012 Corvettes at Carlisle event but the car was pulled at the last minute because of a dispute over ownership.
Upon learning of the rediscovery of the famous Corvette, a man by the name of Dan Mathis Jr. claimed the car was stolen from his father during the 1970s. Two car collectors Gino Burelli and Domenico Idoni teamed up with Mathis and the matter headed to court.
According to PennLive, U.S. Middle District Judge John E. Jones III settled the matter in 2015, by dividing the ownership rights between Mackay, Idoni and Burelli. Mathis pulled out of the legal tussle earlier by selling his stake to Idoni and Burelli.
High-Res Gallery: #1 Briggs Cunningham 1960 Chevrolet Corvette - Image via Motor.es
24 Hours of Le Mans Chevrolet Corvette News Chevrolet News Classic Cars Racing
Guy who 'discovered' abandoned Mercedes gullwing aims to open UAE car museum
Long-Lost Briggs Cunningham Corvette On Show At Corvettes At Carlisle
World's first Shelby Cobra headed to auction
Now there are seven (or maybe nine): Bugatti Royale prototype re-created
Aston Martin F1 team readies new headquarters at Silverstone Racing January 19, 2021
Ecurie Ecosse launches Jaguar C-Type continuation car Classic Cars January 16, 2021
Bentley built just 100 examples of the 8 Litre, and Jay Leno has one Classic Cars January 12, 2021
ByKolles reveals Le Mans Hypercar racer and road car Racing January 15, 2021


76% of the ratings for 9148100014 have been negative.
18 blockings of 9148100014 altogether. None during the last 30 days.
17 ratings for 9148100014 altogether. No rating during the last 30 days.
90 calls from 9148100014 altogether. No call during the last 30 days.
4 searches for 9148100014 altogether. No search during the last 30 days.


text:
Oregon Sports Properties is a division of Learfield which handles the sports broadcasting, accommodation, and billboard rights for the teams of the University of Oregon's athletic programs and its venues. Until 2012, it was known as the Oregon Sports Network (abbreviated to OSN) and also handled the school's television rights. It launched in 1987 to handle the team's radio rights, with KUGN in Eugene the school's longtime flagship radio station since 1959, outside the period between 1987 and 1995 where KPNW served as the flagship with OSN producing broadcasts. Later, its television coverage aired on NBC Sports Northwest, with additional coverage carried on KLSR and KEVU. OSN contracted with KEZI to host and produce its coaches' shows for football and men's and women's basketball.

The network's television operations were wound down completely by the start of the 2012–13 academic year, when the Pac-12 Networks were launched and OSN's sports rights were given over to the conference, and its remaining audio and web operations are now a part of Learfield.

References

Sports television networks in the United States
Defunct television networks in the United States
Television channels and stations established in 1988
Television channels and stations disestablished in 2012
Oregon Ducks
College sports television networks
1988 establishments in Oregon
2012 disestablishments in Oregon


If you've ever met with a financial planner or investment advisor, then you know that one of the first rules of investing is diversification, an important risk management technique that ensures there are a variety of assets within a portfolio. The rationale behind this technique portends that a portfolio of different kinds of investments will, on average, yield higher returns and pose a lower risk than an investment portfolio that is singularly focused.
Similarly, as biopharmaceutical organizations, it is important that we recognize the dire consequences that may result if we ignore this proven strategy. Consider the high-failure, low-approval percentages for new drugs across the entire industry. The numbers demonstrating diminished productivity in drug discovery have been replayed using many statistics quoted in the media, including the fact that Phase II success rates for new development projects fell from 28 percent in the 2006-2007 period to 18 percent in 2008-2009 (P. Mansell, PharmaTimes).
A relatively unknown fact in our industry is that all of the nearly 25,000 marketed drugs today have evolved from modulation of just 324 molecular targets (J.P. Overington, Nature Reviews Drug Discovery). This statistic implies that much of the progress in patient care is the result of improvements of existing drugs, and not from advances against a novel disease target or mechanism of action. To address the challenges in industry productivity, companies have begun to apply two distinct drug discovery and development strategies.
For Big Pharma, blockbuster drugs of the past may no longer meet their commercial hurdles because they risk not meeting payer reimbursement and medical society care pathway guidelines. The path to meeting those hurdles requires expensive health outcomes research fraught with risk and extended development timelines. With costly investments in new genetic sequencing and data-mining technologies, they instead focus their budgets on novel mechanisms of action, including rare or orphan diseases, which either ensure a market position with no comparators, or where pricing is defensible based on proprietary status and smaller patient populations.
The other group at the commercialization table is focused on simple improvements that can drive short-term revenues using a 505 (b)2 regulatory approval strategy. Using this strategy, a product may have the same active ingredient as a previously approved product, but is formulated in a different delivery system or is developed for a different indication. This approach lowers risk because the applicant can rely on studies from the original drug and simply demonstrate efficacy and safety with the new dose form or in the new area of use. Pricing may be the same or less than the innovator drug, but the superiority of the new delivery form will drive prescribing from the older drug to the newer drug, which is allowed a patent-protected exclusivity position for three or five years, depending on regulatory criteria that the new compound meets. Examples are the development of thalidomide in cancer by Celgene, or Zyrtec D as a decongestant line extension to the antihistamine Zyrtec by Pfizer.
Unfortunately, what's missing in this bifurcated mix is the development of drugs from first in class to best in class. Indeed, over the last 50 years, this strategic approach has played a major role in moving care forward incrementally, and represents the place where the industry has classically generated its greatest share of revenues and profits. Sir James Black, the Nobel prize- winning Scottish doctor and pharmacologist credited with the discoveries of beta-blockers and H2 antagonists, and perhaps singly responsible for more drug revenues (calculated at dollar values today) than any other individual in the 20th century, has said that "the most fruitful basis for the development of a new drug is to start with an old drug."
A recent study by Accenture and CMR found that the probability of a new drug project reaching preclinical development was only 3 percent for novel targets. This is in contrast to historical data from McKinsey and others that show follow-on drugs are inherently less risky. About 1 in 123 of them makes it from earliest discovery all the way to market, which is a rate almost double that of drugs based on novel approaches.
Over the past 20 years, the highest value has come from drugs that entered the market two to five years after a comparable novel one. One needn't look far, with Pfizer's Lipitor as the highest revenue- grossing drug of all time, and a successor from statins that began with Merck's Mevacor and Zocor. The introduction of Tenormin as a selective beta- blocker instead of the non-selective Inderal provided patients with a major difference in their ability to tolerate beta-blocker therapy. This data forecasts that a company pursuing only novel targets in its quest for new drug discovery would spend more money and reap lower rewards over the long term.
In the push by the industry to identify compounds with novel molecular mechanisms of action and, in the case of 505(b)2 strategists, find assets that offer a short-term proprietary position along with speed to market, the potential opportunities to move first-in-class agents to best-in-class has been marginalized to the detriment of patients.
The challenge for the industry is in recognizing the scientific and commercial hurdles that must be met to demonstrate improved outcomes. Companies taking this approach need to develop target product profiles that outline the minimal requirements to support further development, and should adhere strictly to the selection menu once established. By establishing criteria around the compound's pharmacokinetic properties, in-vitro and in-vivo data hurdles, side effect and dosing profile and other key attributes, the company can ensure the drug profile is one that will be safe and effective. And by closely analyzing the current and future competitive landscape and market considerations, a company can be more confident that a drug will be commercially accepted by patients, payers and physicians. Companies that ensure these hurdles are met can be assured that their best-in-class compounds will not be considered "me-too" agents, and that chemistry advances will demonstrate the health outcomes advance that change care pathways and help patients.
Outside the biopharmaceutical industry, Apple is a perfect example of this approach in action. As John Moltz recently pointed out in an editorial in Macworld, Apple has a lot of patents (more than 4,100 in the last decade, according to some sources) but they're not around the invention of the mobile phone or the personal computer or the tablet. If you look at the boilerplate text on an Apple press release, it says, "Apple re-invented the mobile phone with its revolutionary iPhone and App store."
The best way to evaluate whether Apple would enter a market is to ask whether people are satisfied with the current user experience. Apple has reinvented existing markets by making the user experience richer, easier and more pleasant, which is Apple's signature competency. The biopharma industry has lost touch with the importance of improving the user experience because of its concerns about reimbursement, but these user experiences often impact outcomes and where the two intersect, there are many opportunities for new discoveries that can improve quality of life and lower health-related costs.
Just as any financial planner stresses portfolio diversification as the best strategy to balance risk and reward, companies should focus on building a diversified portfolio of projects that balances both novel approaches and incremental improvements to demonstrate innovation and value. We need to balance the allure of discovering novel molecular pathways and Wall Street's desire for short-term revenues with the lower risk and achievability of new best-in- class agents that can help achieve the goals of lowering health-related costs, while also enhancing the quality of patient care.
Arthur Hiller is the CEO of SciFluor Life Sciences, a drug discovery company applying expertise in fluorine chemistry to create a portfolio of differentiated best-in-class therapeutics. Based in Cambridge, Mass, SciFluor was established in 2011 in part by the Harvard University Biomedical Accelerator Fund and a Series A investment from Allied Minds. Prior to joining SciFluor, Hiller served as CEO of Heartscape Technologies Inc., where he built a team that raised $22 million in B-round venture financing, achieved placement and sales growth across 30 prestigious institutions nationwide and ultimately reached an exit for sale of the company to a medical device subsidiary of a $5-billion Fortune 1000 company.


Justified by faith: Jesus told the rich man if his family did not believe Moses and the Prophets they would not believe if One were raised from the dead. The just live by faith.
Imagine you were with Jesus in His earthly ministry seeing His works of teaching and healing and feeding. After seeing the abundance of times He ministered to people without fail you still did not believe that He was the Christ.
In truth, not in accusation, did the Pharisees say Jesus was doing His work by the power of the devil. In other words they were not jesting or using a figure of speech but they made a direct charge against Him.
Now perhaps you can see why if they were to see One raised from the dead they would not believe. If they did not believe are seeing everything else Jesus did seeing Him raised from the dead would not bring about their faith.
If the just live by faith what is faith and what is the object of that faith?
Faith is believing the promises of God. In our day the object of faith is the person and work of Jesus Christ. All the promises of God are in Him.
The primary promise is that forgiveness of our sins is in His shed blood and our justification is confirmed by His resurrection from the dead. Therefore we are reconciled to God by faith in the person and work of Jesus Christ.
This faith in Him eliminates confidence in our own works for reconciliation with God. This would mean that God would justify us based on our good deeds but to be justified by faith is to be justified by our faith in Jesus' good deeds.
In this justification Jesus Christ is glorified above all men forever as the One by whom the rest of us are reconciled to God. This is God's goal that while we are on earth Jesus Christ is the supreme man and we all submit to His Lordship.
To conclude, therefore if you don't believe in Moses and the Prophets who spoke of and pointed to the Christ then you won't believe if One was raised from the dead.


CASE OF 3 BDP P102-2025, P0102-2025BB, M8-1056, 9183970. This filter fits BDP air cleaner models CMF2025, P102-BB20, P102-MF20. The nominal size is a 20 x 25 x 5 BDP whole house media filter. The actual size is (H) 20 1/4 x (W)25 3/8 x (D)5 1/4. It maintains the original box type design. It removes atmospheric & household dust, coal & insecticide dust, mites, pollen, tobacco smoke, cooking smoke, grease, mold, fungi & more down to 0.3 micron. This product is listed and rated by Underwriters Laboratories as U.L. Class 2.


Going through your day-to-day life, you may not feel like a "hero." Heroes are confident, right? They perform extraordinary feats. They save the day! But, being a hero is not limited to these scenarios.
Simply, by thinking of your life as an epic story, that makes you its main character, its Hero. The bonus is, that you're also its Author. In Author mode, you can tap into the quiet place in your deepest self and take a high-level look at the happenings in your life like they are events in a story.
In this four-minute video, I share how I view my Author-self as a timeless Inner Observer, and why.


text:
Q: ant-testng task for passing multiple test class names(passing through cmd line args) I want to invoke an ant task which should accept multiple test classes for testng and run(not suite xml),
very similar to   but comma separated list of test classes. I could not find any clue when I checked the documentation.
Is there a possibility, Please let me know.
This is my ant task to run a single test:
<target name="run-class"
    description="run a specific test class. Requires class.name property set to fully-qualified name of class">
    <some properties />
    <testng classpathref="lib.path"
            outputDir="${outputDir}"
            workingDir="${workingDir}"
            verbose="2"
            useDefaultListeners="false"
            listeners="${testng.listeners}"
            className="${class.name}"
            delegateCommandSystemProperties="true"
            configFailurePolicy="continue">
        <jvm params/>
    </testng>
</target>

I would invoke this as :  ant run-class -Dclass.name=com.vmware.CreateVM -DParallel=true
I would like to provide another ant task as above which should accept multiple test classes(but not as a suite xml file)

A: Please refer to TestNG Ant Task documentation and look at the classpath and
classpathref attributes and classfileset element.

redpajama_set_name: RedPajamaStackExchange


text:
Accused killer: Murder charge 'sucks'
James Halpin / Published: May 15, 2019
Devin Malik Cunningham is led by a state trooper into his arraignment at Kingston district court on Tuesday, May 14, 2019. Sean McKeag / Staff Photographer
KINGSTON — Accused killer Devin Malik Cunningham showed up to court Tuesday afternoon in pajama pants with a "s'up" to reporters and a request for people to follow his Instagram page.
Asked for a reaction to charges alleging he and three others brutally murdered 71-year-old Joseph Monka last month, Cunningham maintained his innocence.
"Damn, that s--t sucks. I can't lie," said Cunningham, 20, of Wilkes-Barre. "But I'm going to have to deal with it."
Magisterial District Judge James J. Haggerty arraigned Cunningham on criminal homicide and conspiracy to commit murder, theft, conspiracy to commit theft, unauthorized use of a vehicle and tampering with evidence. Cunningham was also arraigned on theft charges in an unrelated case alleging he stole $10 from a vehicle.
The judge denied him bail in the murder case, citing the danger posed to the community.
Cunningham was directed to apply for a public defender and was sent to the Luzerne County Correctional facility with a preliminary hearing set for June 7.
After the hearing, Assistant District Attorney Jarrett J. Ferentino vowed to deliver justice for Monka.
"Mr. Monka, as we've said, was an elderly, good member of this community," Ferentino said. "He was related to one of the defendants. It's a tragic case. It is a violent case, but it is one we intend to see through our system and hold these four individuals accountable."
Cunningham's co-defendants include Monka's 17-year-old granddaughter, Gabriella Long, as well as Christopher Cortez, 19, of Wilkes-Barre, and Mercedes Lin Hall, 16, of Kingston.
Monka was brutally beaten and stabbed in the neck at his home at 30 Arch St., Edwardsville, on April 15 before his granddaughter and her friends stole his car and roughly $30,000 he kept in a basement safe, according to state police.
Monka's bloody body was discovered underneath a large dresser on the second floor of his home two days later after witnesses entered the ransacked property to check on his welfare.
Police arrested Long, Cortez and Hall at a Plains Twp. hotel early the morning of April 18, hours after Monka's body was discovered.
U.S. marshals captured Cunningham at his mother's home in Fairfax, Virginia on April 25. He had been held in Virginia until Pennsylvania State Police brought him back Tuesday.
All four defendants are charged with criminal homicide, conspiracy to commit murder, theft, conspiracy to commit theft, unauthorized use of a vehicle and tampering with evidence.
They are being held at the Luzerne County Correctional Facility without bail.
jhalpin@citizensvoice.com


text:
Ty Darlington (born December 3, 1994) is an American football coach and former center who is currently the tight ends coach at Incarnate Word. He played college football at Oklahoma, where he was a two-time Academic All-American and won both the Wuerffel Trophy and William V. Campbell Trophy in his senior season.

Playing career

College
Darlington committed to playing college football at Oklahoma in 2011, a school that he grew up a fan of as his mother was a cheerleader for the Sooners. While at Oklahoma, he took part in a number of activities, where he was a leader of a Fellowship of Christian Athletes group, a vice chairman on the Student-Athletes Advisory Committee at OU, and a team captain for football. He was also a stellar student-athlete, compiling a 3.91 cumulative GPA while at Oklahoma, the only non-A he received being a B in a strength & conditioning course. As a senior, he racked up awards, being named the recipient of the William V. Campbell Trophy, an award that considered the student-athlete equivalent of the Heisman Trophy and the Wuerffel Trophy, an award given to the player who combines community service with athletics and academics. He was also named to the 2015 All-Big 12 Conference first-team.

Professional
Darlington signed a professional contract with the Tennessee Titans after going undrafted in 2016, but did not make the team. He retired from professional football shortly after and joined the athletics department at his alma mater Oklahoma as an administrative fellow and for Sooner Sports TV.

Coaching career
Darlington joined the Oklahoma coaching staff in 2017 as an offensive quality control coach. He was reassigned to a graduate assistant role in 2020.

References

External links

 Oklahoma profile
 National Football Foundation profile

1994 births
Living people
People from Apopka, Florida
Players of American football from Florida
Coaches of American football from Florida
American football centers
Oklahoma Sooners football players
Tennessee Titans players
Oklahoma Sooners football coaches


My first ever (and only other) visit to Homecomin' was not a successful one. Due to the positive reviews and appealing menu, it was a meal that my friends and I had been greatly looking forward to. But we were disappointed with the service, as well as most of the many foods we tried. However, in the year between that visit and this trip I continued to hear great things about Homecomin' so I decided to give it another try.
So did I regret giving Homecomin' a do over? Let's find out, shall we?
…which was actually pretty nice. There were only a few other guests seated out there so it was quiet and relaxing.
This salad was truly delicious! There wasn't anything I didn't like about it…even the fried chicken was perfect this time.
I wasn't expecting there to be so many. There were at least 6 biscuits in this basket. I had one with my salad (it too was delicious) and took the rest of them home with me to share with my husband over the next few days. Even leftover and reheated these biscuits were great!
This was a slice of heaven! A huge slice of heaven! I ate a small piece of this along with the ice cream and then had them box up the rest of the cake to take home. I also shared this with my husband and he too loved it, even though (with the exception of carrot cake) he does not like cake.
As for the service, like the food it too was much improved from my last visit to Homecomin'. Therefore, this final meal turned out to be one of the best, if not the best of my trip and I was very glad that I gave Homecomin' a second chance.
So that just leaves the ratings and rankings. Based only on this meal, I would rate Homecomin' a perfect 5. Yelp reviewers though rated it a 4 but on Trip Advisor Homecomin' received a rating of 4 1/2. It also ranks pretty high on Trip Advisor, coming in at #95 of the more than 3,000 Orlando area restaurants reviewed there. And narrowing it to just the Disney World area restaurants, Chef Art Smith's Homecomin' ranks an impressive #23.


On this episode of Breaking Trail, Coyote has a Termite breakfast with an Anteater!
While visiting Kids Saving the Rainforest's wildlife sanctuary and rehabilitation center in Costa Rica the Brave Wilderness team was lucky enough to join a baby Tamandua for his daily breakfast. It is very important that these young residents of the sanctuary learn where their vital food sources come from so they are prepared for a successful life back in the wild.
So after "Mr. Bean" had his fill Coyote thought why not try some Termites for himself? They are an excellent source of protein after all!
Get ready for one delicious Termite Breakfast! Yum!
*Kids Saving the Rainforest never lets the public touch or see the baby wildlife. We only do so when the filming is to educate, which is our mission. All wildlife caretakers were present during filming to guarantee the animal's well-being and assure to that they weren't under stress. Remember, it is never acceptable to have a wild animal as a pet!.
Follow along with adventurer and animal expert Coyote Peterson and his crew as they lead you on three exciting expedition series - Emmy Award Winning Breaking Trail, Dragon Tails and Coyote's Backyard - featuring everything from Grizzly Bears and Crocodiles to Rattlesnakes and Tarantulas…each episode offers an opportunity to learn something new.
GET READY...things are about to get WILD!
GIGANTIC Toad Found in Japan!


It is easy to understand why Miss Toward spent most of her time at home in the kitchen. This small room faces the back garden and had everything she needed: a cosy box bed, a big cast-iron range, a sink with a wringer, a pantry and all her cooking utensils. Almost 90% of the objects in the Tenement House belonged to this remarkable lady and are a reflection of her daily life.
At a time when electricity was uncommon in houses and few people owned a refrigerator, shopping was done very differently. Going for the 'messages' was a daily activity and almost a social event, where people visited small family-owned shops in the local area and received deliveries of goods such as coal and milk. Miss Toward was a member of the St George's Co-operative Society at St George's Cross, which was founded in 1870 With local branches across Scotland, co-operative societies built their own factories, produced their own goods and shared all the profits with their customers. The metal can pictured was supplied by St George's co-op for delivering milk. Once it had been emptied by the recipient, the delivery boy would collect it on his second round in the area.
The most captivating object we found is an unopened orange marmalade jar made by Wilkin & Sons, dated 1941 and still in its original packaging. During WWII the main task of the Ministry of Food was to oversee rationing in the United Kingdom, keeping prices down and promoting recipes that worked with the rationing system. Amazingly, during those difficult years Wilkin & Sons managed to keep producing their original recipes with their high fruit content. The price on this jar, authorised by the Minister of Food, is 1/3 shilling per lb, which equates to around £1.40 in today's money.
Project Reveal is a Trust-wide collections digitisation project. It will result in an updated database with high-quality images and unique object numbers for every item in the Trust material culture collections. Six regionally based project teams, supported by experienced project managers, will work across all of our properties with collections to complete the inventory in 18 months from July 2017 until December 2018.
With the Project Reveal teams now settled at their various regional bases, we thought this would be a good time to introduce them.


text:
Our Clinical Leads
About Mind Therapies Treatments We Offer Treatment Packages Difficulties We Treat What to expect from psychological treatment Types of Psychological Treatment Clinic Locations How to refer
What Is Autism Sign and Symptoms of Autism Multidisciplinary Gold Standard Assessments Waiting times for NHS diagnosis EHCP: Is a private diagnosis recognised? What Autism-specific tools do we use? What to expect from the assessment Child Assessments Adult Assessments Benefits Of Having An Assessment How to refer How to Pay
Multidisciplinary Gold Standard Assessments Waiting times for NHS Assessments Is a private diagnosis recognised? What Autism-specific tools do we use? What to expect from your autism assessment Child Assessment - What to expect Adult Assessment - What to expect Benefits of having an assessment What is Autism Signs and Symptoms of Autism How to refer
Psychological Therapy
About Mind Therapies Treatments we offer Treatment packages Difficulties we treat What to expect from treatment Types of treatment Clinic locations How to refer
Law Firms, NHS and Business
What we do Why Choose Us? Law Firm, Rehab & Insurance providers NHS Services Business, HR & Occupational Health Depts Services for Private Individuals Ensuring Successful Outcomes Autism Diagnostic Service Psychological Therapy Service How to refer
Mind Professionals
1 Stow Court
Stow Road, Stow-Cum-Quy
Cambridge CB25 9AS
T: +44 [0]1223 813838
F: +44 [0]1223 812046
E: enquiries@mindprofessionals.com
> Our Clinical Leads
> About Mind Therapies
> Treatments We Offer
> Treatment Packages
> Difficulties We Treat
> What to expect from psychological treatment
> Types of Psychological Treatment
> Clinic Locations
> How to refer
> What Is Autism
> Sign and Symptoms of Autism
> Multidisciplinary Gold Standard Assessments
> Waiting times for NHS diagnosis
> EHCP: Is a private diagnosis recognised?
> What Autism-specific tools do we use?
> What to expect from the assessment
> Child Assessments
> Adult Assessments
> Benefits Of Having An Assessment
> How to Pay
> Autism Diagnosis
>> Multidisciplinary Gold Standard Assessments
>> Waiting times for NHS Assessments
>> Is a private diagnosis recognised?
>> What Autism-specific tools do we use?
>> What to expect from your autism assessment
>> Child Assessment - What to expect
>> Adult Assessment - What to expect
>> Benefits of having an assessment
>> What is Autism
>> Signs and Symptoms of Autism
>> How to refer
> Psychological Therapy
>> About Mind Therapies
>> Treatments we offer
>> Treatment packages
>> Difficulties we treat
>> What to expect from treatment
>> Types of treatment
>> Clinic locations
> Law Firms, NHS and Business
>> What we do
>> Why Choose Us?
>> Law Firm, Rehab & Insurance providers
>> NHS Services
>> Business, HR & Occupational Health Depts
>> Services for Private Individuals
>> Ensuring Successful Outcomes
>> Autism Diagnostic Service
>> Psychological Therapy Service
> Register with us
Types of Psychological Treatment
Cognitive Behavioural Therapy or CBT is a Talking Therapy. It is an evidence based intervention which has been proven to help treat a wide range of psychological, emotional and physical health conditions in adults, young people and children. CBT looks at how the way we think about a situation affects the way we feel and act. In turn our actions can affect how we think and feel.
Clinicians work collaboratively with the client to explore, identify and change unhelpful thinking and behavioural patterns maintaining the cycle of emotional distress.
The British Association of Behavioural and Cognitive Psychotherapies (BABCP) website provides more information about what CBT is and its effectiveness with a range of anxiety, depression and other mental health problems.
Click here to learn more about CBT
The NHS Choices website provides patient information and videos to advise patients considering CBT
Clink here for more about NHS Choices
EMDR – Eye Movement Desensitisation and Reprocessing
Eye Movement Desensitisation and Reprocessing Therapy (EMDR) was developed as a treatment of Post-Traumatic Stress Disorder (PTSD) and other trauma-related difficulties. A substantial evidence base for its effectiveness in treating trauma has been established and it is now a recommended treatment for PTSD. The EMDR treatment approach has been further developed so that it can now also be used to treat to a number of other mental health difficulties, such as depression, phobias and obsessive-compulsive disorder.
Traumatic events can overwhelm our natural healing mechanisms. As a result memories of traumatic events can be stored in the brain in an unprocessed, emotionally-charged way. It is proposed that EMDR works by unblocking the mind's natural healing processes allowing us to fully process memories of traumatic events and achieve significant reduction in the emotional distress associated with the memory.
In comparison to other Psychological treatments, EMDR relies less on talking and clinician interpretation. Rather, using detailed protocols and procedures, clinicians help clients activate their own natural healing processes.
MBCT – Mindfulness Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy (MBCT) is a modified form of cognitive therapy that incorporates a variety of mindfulness techniques. It was originally developed to prevent relapse in people with recurring episodes of depression or unhappiness. It has been proven effective in patients with major depressive disorder who have experienced at least three episodes of depression. Mindfulness has a growing research base and may be beneficial to people experiencing ruminative thinking, anxiety, addictions and chronic pain. People who regularly practice mindfulness have experienced lasting physical and psychological benefits, such as an improvement in concentration, memory and energy levels; reduction of stress and emotional reactivity; increase in positive emotions and the ability to be more accepting and compassionate.
MBCT teaches techniques that help us to connect to our immediate experience with curiosity, acceptance and openness rather than withdrawing from or trying to change our experience. Mindfulness techniques can be practiced on a formal or informal basis and may include focusing on the breath, using our senses to connect to our surroundings, bringing awareness to our thoughts and feelings and letting go of judgmental and unhelpful thoughts. In essence, mindfulness allows us to gain more control of our lives by increasing self-awareness, attention control, and the capacity to distance ourselves from unhelpful thoughts and feelings. This gives us the freedom to choose how to respond effectively, rather than get caught up in the content of our thinking and react in unhelpful ways.
ACT – Acceptance and Commitment Therapy
Acceptance and Commitment Therapy (ACT) is an effective psychological therapy that uses acceptance and mindfulness interventions alongside identifying a person's life values and using commitment and behaviour change strategies to enhance psychological flexibility and reduce emotional distress.
Please find further information about Acceptance and Commitment Therapy by clicking on either of the links below:
Click here for more about ACT Click here for more about Self Help
CFT – Compassion Focused Therapy
Compassion Focused Therapy (CFT) is a form of Cognitive-Behavioural Therapy (CBT) that draws upon evolutionary psychology and the neuroscience of emotion to help people work through emotional difficulties.
CFT aims to develop ways to understand compassion and how to apply it to ourselves in our own lives, in overcoming emotional distress, such as shame and guilt which can be common experiences following trauma. Many clinicians use aspect of Compassion Focused Therapy alongside other treatment approaches.
Please find further information about Compassion Focused Therapy by clicking on the link below:
Click here for more about Compassion Focused Therapy
DBT – Dialectical Behaviour Therapy
Dialectical Behaviour Therapy (DBT) is a type of Cognitive Behavioural Therapy. Its main goals are to teach people skills to strengthen their capacity to recognise and tolerate emotional experiences, cope healthily with stress, regulate emotions, and improve relationships with others. A key underlying principal of DBT is validation of a person's current difficulty while also focussing on the skills required to help change the issue.
DBT was originally intended for people with Borderline Personality Disorder (sometimes referred to as Emotionally Unstable Personality Disorder) but has since been adapted for other conditions where difficulty managing the ebbs and flows of emotion is apparent such as anger, self-injurious behaviour, eating disorders and substance abuse. It is also sometimes used in the treatment of Post-Traumatic Stress Disorder.
Please find further information about Dialectical Behaviour Therapy by clicking the link below
Click here for more about Dialectical Behaviour Therapy
Behavioural Activation
Behavioural Activation is a treatment for depression or low mood that has been found to be very effective, even for clients who have not had success with other approaches. This treatment approach works from the assumption that negative life events such as grief, trauma, daily stressors, or a genetic predisposition to low mood can lead to a person having too little positive reinforcement. Additionally, a person might turn to unhealthy behaviours (e.g. drug use, sleeping late into the afternoon, social withdrawal) in an attempt to avoid negative feelings. Although such behaviours provide temporary relief, they ultimately result in more negative outcomes, and worsening mood.
The focus of treatment in this approach is on making changes to our actions or behaviour and our environment in order to improve mood. Techniques aim to increase the amount of positive reinforcement and reduce the amount of negative reinforcement a person experiences by increasing rewarding behaviours and replacing unhelpful or avoidant behaviours.
1 Stow Court,
Privacy | T&Cs | Cookies | Sitemap
© 2021 Mind Professionals. All rights reserved.
Registration No. 05122960. VAT No. 856056413
Design: recolo design


Mixel was an iPad application that used collage as a medium to create art. Art could be shared with others who could use the same collage elements to create their own versions. As a result, Mixel members drew a lot of inspiration from each other and connected as a community. The following images are examples from various members of the community.


TransUnion Customer Service Phone Numbers Info.
If you searching for TransUnion Customer Service Number, you are at the right place. In this post, we have provided a list of TransUnion Customer Service Phone Numbers. You can call TransUnion Customer Support the TransUnion 800 Phone Number given here and solve your queries.
TransUnion was originally formed in 1968 as a holding company for the railroad leasing organization, Union Tank Car Company. The following year, it acquired the Credit Bureau of Cook County, which possessed and maintained 3.6 million card files. In 1981, a Chicago-based holding company The Marmon Group acquired TransUnion for approximately $688 million. Almost thirty years later, in 2010, Goldman Sachs Capital Partners and Advent International acquired it from Madison Dearborn Partners In 2014, TransUnion acquired Hank Asher's data company TLO. On June 25, 2015, TransUnion became a publicly traded company for the first time, trading under the symbol TRU.
Got some questions? Or some suggestions about TransUnion Customer Service? That's why we've got a comments section on this blog! You can feel free to leave a comment or two down below and we'll get back to you as soon as possible!


Stainless steel chain set featuring an extra long 110cm neck chain for those of a 'powerful' build or if you simply want the tags to hang lower than normal.
These extra long dog tag chains can also be trimmed to length using side cutters or strong scissors so you can choose your own chain length.
Incredibly strong and durable 2.4mm ball diameter chains in 304 grade stainless steel.
Includes one long 110cm inch neck chain and one 11.5cm short link chain with connectors.
Guaranteed nickel free and exactly as supplied to US forces.